UPDATE : Monday, September 7, 2020
상단여백
MSD Korea, Mundipharma Korea in mandatory work-from-home mode, again
MSD Korea and Mundipharma Korea ordered their employees to work from home a...
by Kim Yun-mi  |  2020-05-12 11:57
라인
SGLT-2 inhibitor’s renal function benefit recognized limitedly
Long-term sodium-glucose transport protein-2 (SGLT-2) inhibitor treatments ...
by Kim Yun-mi  |  2020-05-11 14:48
라인
‘Roche’s Kadcyla allows early breast cancer patients to continue social life’
Roche Korea obtained additional indication approval for Kadcyla (ingredient...
by Kim Yun-mi  |  2020-05-08 15:51
라인
‘Government should stock Covid-19 vaccines even after virus disappears’
“To develop a vaccine for the new coronavirus infection, it is important to...
by Kim Yun-mi  |  2020-05-07 16:43
라인
US expert notices Korea’s response to Covid-19 outbreak at call center
A report by the Korean Centers for Disease Control and Prevention on its re...
by Kim Yun-mi  |  2020-05-06 15:48
라인
New law takes effect to spur growth of in vitro diagnostic devices
The government said it would promote the growth of in vitro diagnostic medi...
by Kim Yun-mi  |  2020-05-01 15:35
라인
‘Keytruda alone works as first-line therapy for lung cancer’
MSD’s immunotherapy Keytruda (ingredient: pembrolizumab) should be a standa...
by Kim Yun-mi  |  2020-04-29 11:40
라인
Researchers start testing pancreatitis drug to fight Covid-19
The Ministry of Food and Drug Safety has approved a local investigator-init...
by Kim Yun-mi  |  2020-04-28 11:22
라인
Multinational drugmakers donated ₩30 billion last year
Twenty-eight multinational pharmaceutical companies operating in Korea dona...
by Kim Yun-mi  |  2020-04-23 15:09
라인
Samsung app wins nod for checking blood pressure on smartwatch
Samsung Electronics has won approval for its mobile application to measure ...
by Kim Yun-mi  |  2020-04-21 16:59
라인
Researchers to test asthma drug to treat Covid-19
Local infectious disease specialists said they would evaluate the potential...
by Kim Yun-mi  |  2020-04-16 16:20
라인
Opdivo’s indication expanded to esophageal squamous cell carcinoma
A new treatment option has become available in the local esophageal cancer ...
by Kim Yun-mi  |  2020-04-16 10:48
라인
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why?
Gilead Sciences’ last-minute modification of the clinical design of remdesi...
by Kim Yun-mi  |  2020-04-10 15:36
라인
Review of cancer drug benefits delayed amid social distancing
The government has postponed the health authorities’ meeting for a review o...
by Kim Yun-mi  |  2020-04-08 13:46
라인
‘Computerized insulin infusion controls glucose faster, safer’
Local researchers said they have developed a computerized intravenous insul...
by Kim Yun-mi  |  2020-04-07 18:38
라인
Pfizer, MSD put off reorganizing due to COVID-19
Pfizer and MSD have postponed their scheduled organizational reshuffle beca...
by Kim Yun-mi  |  2020-04-03 17:09
라인
‘Early aspirin cut reduced bleeding in acute coronary syndrome patients’
Discontinuing aspirin was beneficial to prevent ischemic events and reduce ...
by Kim Yun-mi  |  2020-04-02 15:08
라인
Korea could lead global standard for infectious disease diagnosis
Korea is expected to lead the development of international standards for th...
by Kim Yun-mi  |  2020-03-30 16:03
라인
[Feature] Medical societies shift to online conferences in light of COVID-19
Medical societies at home and abroad, which had canceled or delayed annual ...
by Kim Yun-mi  |  2020-03-30 14:30
라인
2 drugmakers react differently to coronavirus pandemic
With the new coronavirus hitting the globe more extensively, a manufacturer...
by Kim Yun-mi  |  2020-03-26 13:36
여백
여백
여백
Back to Top